BR Research - Pharmaceuticals

AGPL IPO: A liquidity event

AGPL IPO: A liquidity event

Pharma MNC’s used to dominate the local market about a decade ago. Not so anymore! Helped in part by years of regulatory indifference, the tables...

A case for contract manufacturing

A case for contract manufacturing

Pakistan’s pharmaceutical industry has often been highlighted as a sector of potential growth, both domestically as well as in terms of exports. One little thing...

Ferozsons: not as bad as it looks!

Ferozsons: not as bad as it looks!

At a glance, it looks like Ferozsons Laboratories Limited (PSX: FEROZ) is in deep trouble; for the nine months ended FY17, the Lahore-based pharmaceutical company’s...

GSK healthy as ever

GSK healthy as ever

The largest multinational pharmaceutical company in Pakistan, GlaxoSmithKline Pakistan Limited (PSX: GLAXO) has had an amazing first quarter. For the three months ended 2017, the...

Abbott Laboratories: Strong top line growth

Abbott Laboratories: Strong top line growth

Pakistan’s second-largest pharmaceutical company by market share, Abbott Laboratories (Pakistan) Limited (PSX: ABOT) has announced its results for its first quarter of 2017. Although the...

Cement’s race: No finish line

Cement’s race: No finish line

If you read our last story on the subject in January, our tally for cement expansions stood somewhere between 23-25 million tons. But in the...

Abbott impressive FY16

Abbott impressive FY16

Abbott Laboratories (Pakistan) Limited (PSX: ABOT) announced its stellar result for FY16 which saw the company keeping its increased profitability trend intact. The companys sales...

Close
Close